Datavant and Indegene partner to power more efficient clinical trial recruitment

image credit- shutterstock

US-based Datavant, the data collaboration platform trusted for healthcare, has announced a strategic partnership with Bengaluru-based Indegene, a leading digital-first, life sciences commercialisation company, to enhance patient recruitment for clinical trials, with a focus on rare disease and other complex studies.

By embedding Datavant’s bespoke data enrichment capabilities into Indegene’s NEXT Patient Recruitment platform, the two companies are enabling faster trial enrollment, fewer screen failures, and more efficient recruitment processes for biopharmaceutical organisations.

Patient recruitment is one of the biggest hurdles in clinical development, particularly in rare diseases where eligible populations are small and dispersed. Datavant operates the nation’s largest health data retrieval network, spanning more than 80,000 hospitals and clinics and processing over 100 million patient records annually.

Combined with Indegene’s suite of digitally powered solutions for clinical trial recruitment, the partnership streamlines the identification of suitable participants for studies based on specific health data criteria.

The result is more eligible participants have an opportunity to connect to the trials designed for their specific health conditions, including patients with rare and complex diseases. The partnership enables biopharma companies to reduce site-level screen failures, accelerate enrollment timelines, improve the screen-to-randomisation ratios, and drive more informed decision-making.